Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1954 1
1955 1
1965 1
1969 1
1976 2
1978 1
1980 1
1985 1
1986 3
1987 1
1988 2
1991 1
1992 1
1997 1
1998 1
2000 1
2002 1
2007 2
2009 1
2010 2
2011 2
2013 1
2014 2
2015 1
2016 5
2017 11
2018 9
2019 12
2020 14
2021 11
2022 11
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Smagunov
Page 1
Tips And Tricks for Proteome Sample Preparation.
Doucette AA. Doucette AA. J Vis Exp. 2023 Feb 3;(192). doi: 10.3791/64830. J Vis Exp. 2023. PMID: 37602878
An integrated workflow of identification and quantification on FDR control-based untargeted metabolome. Journal of Visualized Experiments. doi: 10.3791/63625-v (2022). Petelski, A. A., Nikolai Slavov, N., Specht, N. Single-cell proteomics preparation for mass spectr …
An integrated workflow of identification and quantification on FDR control-based untargeted metabolome. Journal of Visualized Experiments. d …
Nikolay Zelinsky (1861-1953): Mendeleev's Protege, a Brilliant Scientist, and the Top Soviet Chemist of the Stalin Era.
Beloglazkina EK, Bogatova TV, Nenajdenko VG. Beloglazkina EK, et al. Angew Chem Int Ed Engl. 2020 Nov 16;59(47):20744-20752. doi: 10.1002/anie.202005233. Epub 2020 Sep 3. Angew Chem Int Ed Engl. 2020. PMID: 32881264 Review.
This Essay outlines the life path and scientific achievements of Nikolai Zelinsky to testify to his contributions to organic chemistry, catalysis, and petrochemistry. ...
This Essay outlines the life path and scientific achievements of Nikolai Zelinsky to testify to his contributions to organic chemistr …
Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study.
Anstee QM, Lucas KJ, Francque S, Abdelmalek MF, Sanyal AJ, Ratziu V, Gadano AC, Rinella M, Charlton M, Loomba R, Mena E, Schattenberg JM, Noureddin M, Lazas D, Goh GBB, Sarin SK, Yilmaz Y, Martic M, Stringer R, Kochuparampil J, Chen L, Rodriguez-Araujo G, Chng E, Naoumov NV, Brass C, Pedrosa MC. Anstee QM, et al. Hepatology. 2023 Oct 1;78(4):1223-1239. doi: 10.1097/HEP.0000000000000439. Epub 2023 May 11. Hepatology. 2023. PMID: 37162151 Free PMC article. Clinical Trial.
Cytokine Imbalance as a Biomarker of Treatment-Resistant Schizophrenia.
Shnayder NA, Khasanova AK, Strelnik AI, Al-Zamil M, Otmakhov AP, Neznanov NG, Shipulin GA, Petrova MM, Garganeeva NP, Nasyrova RF. Shnayder NA, et al. Int J Mol Sci. 2022 Sep 26;23(19):11324. doi: 10.3390/ijms231911324. Int J Mol Sci. 2022. PMID: 36232626 Free PMC article. Review.
Biologist Nikolai K. Koltzoff: the forgotten genius.
Ptushenko VV, Ramensky EV. Ptushenko VV, et al. Genetics. 2023 May 4;224(1):iyad033. doi: 10.1093/genetics/iyad033. Genetics. 2023. PMID: 36946062
Among his disciples, there are the geneticists B.L. Astaurov, S.S. Chetverikov, N.P. Dubinin, V.P. Efroimson, I.A. Rapoport, V.V. Sakharov, and N.V. Timofeeff-Ressovsky; histologist G.I. ...Lapchinsky, developmental biologist M.M. Zavadovsky, physiolog …
Among his disciples, there are the geneticists B.L. Astaurov, S.S. Chetverikov, N.P. Dubinin, V.P. Efroimson, I.A. Rapoport, V …
A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML.
Garcia-Manero G, Podoltsev NA, Othus M, Pagel JM, Radich JP, Fang M, Rizzieri DA, Marcucci G, Strickland SA, Litzow MR, Savoie ML, Medeiros BC, Sekeres MA, Lin TL, Uy GL, Powell BL, Kolitz JE, Larson RA, Stone RM, Claxton D, Essell J, Luger SM, Mohan SR, Moseley A, Appelbaum FR, Erba HP. Garcia-Manero G, et al. Leukemia. 2024 Jan;38(1):58-66. doi: 10.1038/s41375-023-02073-x. Epub 2023 Nov 7. Leukemia. 2024. PMID: 37935977 Clinical Trial.
S1203 was a randomized multicenter trial for previously untreated patients aged 18-60 with AML which compared daunorubicin and cytarabine (DA), idarubicin with higher dose cytarabine (IA) and IA with vorinostat (IA + V). The primary endpoint was event free survival (EFS). …
S1203 was a randomized multicenter trial for previously untreated patients aged 18-60 with AML which compared daunorubicin and cytarabine (D …
Adverse outcome pathways: opportunities, limitations and open questions.
Leist M, Ghallab A, Graepel R, Marchan R, Hassan R, Bennekou SH, Limonciel A, Vinken M, Schildknecht S, Waldmann T, Danen E, van Ravenzwaay B, Kamp H, Gardner I, Godoy P, Bois FY, Braeuning A, Reif R, Oesch F, Drasdo D, Höhme S, Schwarz M, Hartung T, Braunbeck T, Beltman J, Vrieling H, Sanz F, Forsby A, Gadaleta D, Fisher C, Kelm J, Fluri D, Ecker G, Zdrazil B, Terron A, Jennings P, van der Burg B, Dooley S, Meijer AH, Willighagen E, Martens M, Evelo C, Mombelli E, Taboureau O, Mantovani A, Hardy B, Koch B, Escher S, van Thriel C, Cadenas C, Kroese D, van de Water B, Hengstler JG. Leist M, et al. Arch Toxicol. 2017 Nov;91(11):3477-3505. doi: 10.1007/s00204-017-2045-3. Epub 2017 Oct 19. Arch Toxicol. 2017. PMID: 29051992 Review.
110 results